The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I safety and pharmacokinetic (PK) study of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients (pts) with advanced pancreatic cancer (APC) who have cholestatic hyperbilirubinemia (CH) secondary to bile duct obstruction.
 
Hanno Riess
Consulting or Advisory Role - AstraZeneca; Celgene; Merck
 
Volker Kunzmann
Consulting or Advisory Role - Celgene
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
 
Thomas Seufferlein
Honoraria - Amgen; Bayer Schering Pharma; Celgene; Falk Foundation; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Lilly; Merck Serono
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Bayer Schering Pharma; Celgene; Merck Serono; Roche; Sanofi
 
Desmond Micahel Thomas McGovern
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Peng Chen
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Alfredo Romano
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Ramesh K. Ramanathan
Honoraria - Caris Life Sciences; Celgene; Genentech; Immunomedics; Lilly; Sanofi; Taiho Pharmaceutical; Vaccinex
Consulting or Advisory Role - Caris Life Sciences; Celgene; Genentech; Immunomedics; Lilly; Sanofi; Taiho Pharmaceutical; Vaccinex
Speakers' Bureau - Celgene
Research Funding - Abbvie; AVEO; Bayer; Biomarin; Celgene; Dekkun Corporation; Endocyte; Genentech; Halozyme; Merck/Schering Plough; Merrimack; Sanofi; Tekmira; Vaccinex; Verastem
Travel, Accommodations, Expenses - Biomarin